141 related articles for article (PubMed ID: 26679196)
1. The effect of particle shape and size on cellular uptake.
Zheng M; Yu J
Drug Deliv Transl Res; 2016 Feb; 6(1):67-72. PubMed ID: 26679196
[TBL] [Abstract][Full Text] [Related]
2. The effects of polymeric nanostructure shape on drug delivery.
Venkataraman S; Hedrick JL; Ong ZY; Yang C; Ee PL; Hammond PT; Yang YY
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1228-46. PubMed ID: 21777633
[TBL] [Abstract][Full Text] [Related]
3. Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications.
Mathaes R; Winter G; Besheer A; Engert J
Expert Opin Drug Deliv; 2015 Mar; 12(3):481-92. PubMed ID: 25327886
[TBL] [Abstract][Full Text] [Related]
4. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
Nam HY; Kwon SM; Chung H; Lee SY; Kwon SH; Jeon H; Kim Y; Park JH; Kim J; Her S; Oh YK; Kwon IC; Kim K; Jeong SY
J Control Release; 2009 May; 135(3):259-67. PubMed ID: 19331853
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
6. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Microparticle Shape on Cellular Uptake.
He Y; Park K
Mol Pharm; 2016 Jul; 13(7):2164-71. PubMed ID: 26905216
[TBL] [Abstract][Full Text] [Related]
8. Role of nanoparticle size, shape and surface chemistry in oral drug delivery.
Banerjee A; Qi J; Gogoi R; Wong J; Mitragotri S
J Control Release; 2016 Sep; 238():176-185. PubMed ID: 27480450
[TBL] [Abstract][Full Text] [Related]
9. Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.
Salatin S; Maleki Dizaj S; Yari Khosroushahi A
Cell Biol Int; 2015 Aug; 39(8):881-90. PubMed ID: 25790433
[TBL] [Abstract][Full Text] [Related]
10. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
11. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
Gaumet M; Vargas A; Gurny R; Delie F
Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design.
Carraro TC; Khalil NM; Mainardes RM
Pharm Dev Technol; 2016 Mar; 21(2):140-6. PubMed ID: 25384838
[TBL] [Abstract][Full Text] [Related]
14. Shape matters when engineering mesoporous silica-based nanomedicines.
Hao N; Li L; Tang F
Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
[TBL] [Abstract][Full Text] [Related]
15. Skin penetration and distribution of polymeric nanoparticles.
Alvarez-Román R; Naik A; Kalia YN; Guy RH; Fessi H
J Control Release; 2004 Sep; 99(1):53-62. PubMed ID: 15342180
[TBL] [Abstract][Full Text] [Related]
16. Determination of nanostructures and drug distribution in lipid nanoparticles by single molecule microscopy.
Boreham A; Volz P; Peters D; Keck CM; Alexiev U
Eur J Pharm Biopharm; 2017 Jan; 110():31-38. PubMed ID: 27810469
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
18. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?
Baroli B
J Pharm Sci; 2010 Jan; 99(1):21-50. PubMed ID: 19670463
[TBL] [Abstract][Full Text] [Related]
19. Ionically fixed polymeric nanoparticles as a novel drug carrier.
Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
[TBL] [Abstract][Full Text] [Related]
20. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
